Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 11
Submit an article Journal homepage
81
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma

Manik Chahala Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-8862-2028
ORCID Icon,
Anna Haydenb BC Cancer Fraser Valley, Surrey, Canada
,
Kerry J. Savagea Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-5835-9863
ORCID Icon,
Diego Villaa Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-4625-3009
ORCID Icon,
David W. Scotta Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, Canada
,
Alina S. Gerriea Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, Canada
,
Andrea Loc Division of Radiation Oncology, BC Cancer, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-3253-1071
ORCID Icon,
Matthew Chanc Division of Radiation Oncology, BC Cancer, Vancouver, Canada
,
Tom Picklesc Division of Radiation Oncology, BC Cancer, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-2040-4630
ORCID Icon,
Joseph M. Connorsa Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-1361-7531
ORCID Icon,
Laurie Helen Sehna Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0003-1860-9765
ORCID Icon &
Ciara L. Freemana Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, Canada;d H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USACorrespondence[email protected]
 show all
Pages 2739-2742 | Received 19 Apr 2022, Accepted 01 Jun 2022, Published online: 24 Jun 2022

References

  • Sehn LH. Introduction to a review series on hodgkin lymphoma: change is here. Blood. 2018;131(15):1629–1630.
  • Villa D, Sehn LH, Aquino-Parsons C, et al. Interim PET-directed therapy in limited-stage hodgkin lymphoma initially treated with ABVD. Haematologica. 2018;103(12):e590–e3.
  • Moccia AA, Donaldson J, Chhanabhai M, et al. International prognostic score in advanced-stage hodgkin's lymphoma: altered utility in the modern era. J Clin Oncol. 2012;30(27):3383–3388.
  • Brooks EG, Connors JM, Sehn LH, et al. Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical hodgkin lymphoma. Leuk Lymphoma. 2016;57(4):872–879.
  • Aizer AA, Chen MH, Parekh A, et al. Refusal of curative radiation therapy and surgery among patients with cancer. Int J Radiat Oncol Biol Phys. 2014;89(4):756–764.
  • Rapp J, Tuminello S, Alpert N, et al. Disparities in surgery for early-stage cancer: the impact of refusal. Cancer Causes Control. 2019;30(12):1389–1397.
  • Johnson P, Federico M, Kirkwood A, et al. Adapted treatment guided by interim PET-CT scan in advanced hodgkin's lymphoma. N Engl J Med. 2016;374(25):2419–2429.
  • Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage hodgkin's lymphoma. N Engl J Med. 2015;372(17):1598–1607.
  • Hastert TA, Banegas MP, Hamel LM, et al. Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors. J Cancer Surviv. 2019;13(3):429–437.
  • Sorin M, Franco EL, Quesnel-Vallée A. Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program. Curr Oncol. 2019;26(4):266–269.
  • Purificacion SJ, French JG, d'Agincourt-Canning L. Inequities in access to cancer care in Canada: an ethical perspective. Healthc Manage Forum. 2015;28(6):265–269.
  • Gansler T, Kaw C, Crammer C, et al. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the american cancer society's studies of cancer survivors. Cancer. 2008;113(5):1048–1057.
  • Johnson SB, Park HS, Gross CP, et al. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol. 2018;4(10):1375–1381.
  • van Leeuwen FE, Ng AK. Long-term risk of second malignancy and cardiovascular disease after hodgkin lymphoma treatment. Hematology Am Soc Hematol Educ Program. 2016;2016(1):323–330.
  • de Vries S, Schaapveld M, Janus CPM, et al. Long-Term Cause-Specific mortality in hodgkin lymphoma patients. J Natl Cancer Inst. 2021;113(6):760–769.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.